Jacqueline Genovese Bova

Jacqueline Genovese Bova is a senior associate in Goodwin’s Intellectual Property Litigation practice who focuses her practice on patent litigation and post-grant proceedings across federal courts and the Patent Trial and Appeal Board (PTAB). She represents clients in complex disputes involving electronic devices, consumer products, fintech platforms, and pharmaceutical technologies, with experience spanning district court litigation, PTAB inter partes reviews, and licensing-related disputes.

Jacqueline is a trial attorney, having tried several jury and bench trials throughout her career. She has experience representing clients in all stages of litigation, from pre-suit investigation through trial, and also has experience in arbitrations arising from licensing and related commercial agreements:

• Represented a manufacturer in a long-running patent dispute involving core electrical device technology. 
• Represented a consumer products company in patent litigation concerning blade-coating technologies, resolving the matter favorably before trial. 
• Represented pharmaceutical and biosimilar companies in BPCIA litigation involving biologic therapies. 
• Represented a pharmaceutical company in patent litigation concerning iron-replacement therapies, achieving a favorable settlement. 
• Represents clients in PTAB inter partes review proceedings involving consumer technology patents. 
• Represents companies in patent litigation involving semiconductor and electronics technologies. 
• Advises clients on patent licensing disputes and strategic alliance matters involving emerging technologies.

Jacqueline’s representations include:

• Nike, Inc. v. New Balance Athletics, Inc. (D. Mass.): Representing New Balance in a patent infringement lawsuit adverse to Nike concerning textile uppers for footwear in the District of Massachusetts and related inter partes review proceedings.  
• CellCast Techs., LLC v. United States (U.S. Court of Federal Claims): Represented third-party defendant International Business Machines Corporation (IBM) in a patent infringement lawsuit concerning the government’s national alert messaging technology.
• Otsuka Pharmaceutical Co., Ltd. v. Teva Pharmaceuticals USA, Inc. (D. Del.): Represented Teva in a patent infringement action filed by Otsuka and Lundbeck under the Hatch-Waxman Act relating to Teva’s filing of an abbreviated new drug application for a generic version of REXULTI®. The case settled favorably before trial.
• The Gillette Company v. Dollar Shave Club: Represented the Gillette subsidiary of consumer products giant Procter & Gamble in its widely publicized competitor litigation against Dollar Shave Club and its suppliers. Gillette asserted that the defendants’ razor blades violated a Gillette patent directed to innovative blade coatings that provide a more comfortable shave and allow for longer life. After Goodwin secured a successful outcome in an international arbitration and defeated a petition for inter partes review, the patent suit proceeded with Gillette seeking substantial damages. The team secured several important victories along the way, prevailing at claim construction and defeating motions for summary judgment of non-infringement and invalidity. Nearing the eve of trial, the case settled favorably for Gillette.
• Leviton Mfg. Co., Inc. v. Pass & Seymour, Inc. (E.D.N.Y.): Representing defendant Pass & Seymour in a long-running dispute involving P&S’s core technology, ground-fault circuit interrupters (GFCIs).

Pro Bono

Jacqueline maintains an active pro bono practice focused on civil rights and immigration matters. Jacqueline has spearheaded several projects with pro bono partners, including limited-assistance representation of pro-se plaintiffs in §1983 actions, through the New York Legal Assistance Group. Jacqueline has also worked with NY Legal Aid Society’s Exploitation Intervention Project to work with trafficking survivors to help them vacate convictions related to their trafficking and seal the records of those arrests. Her work also includes representing clients in asylum proceedings, and veterans’ discharge matters, as well as advising entrepreneurs through small-business legal initiatives.

Jacqueline serves as vice chair of the Intellectual Property Owners Association’s (IPO) Women in IP Committee. She is also a member of the Federal Bar Council and the New York State Bar Association.

Jacqueline was a law clerk to the Honorable Ramon E. Reyes, Jr. in the Eastern District of New York.

Jacqueline has been recognized by Best Lawyers: Ones to Watch® in America for her expertise in Litigation – Patent (2024-2026), Litigation – Intellectual Property (2026), and Patent Law (2026).

While attending Brooklyn Law School, Jacqueline was a fellow of the Trade Secrets Institute. She was also the Executive Notes & Comments Editor for the Brooklyn Journal of International Law, where her article titled “Biosimilar Naming: A Call for Uniformity in a Complex Field” was published.

• Contributor, “Guide to Biosimilars Litigation and Regulation in the U.S., 2023-2024 ed.,” published by Thomson Reuters, January 2024
• Special Contributor, “Guide to Biosimilars Litigation and Regulation in the U.S., 2022-2023 ed.,” published by Thomson Reuters, December 2022
• Special Contributor, "Guide to Biosimilars Litigation and Regulation in the U.S., 2020-2021 ed.," published by Thomson Reuters, January 2021
• Contributor, "Guide to Biosimilars Litigation and Regulation in the U.S., 2019-2020 ed.," published by Thomson Reuters, November 2019 
• Contributor, “The Biosimilars Litigation Landscape for 2017,” Law360, January 2017